Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-pa
ClinicalTrials.gov study NCT07245797. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS I
ClinicalTrials.gov study NCT02047422. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
ClinicalTrials.gov study NCT00002030. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis
ClinicalTrials.gov study NCT06925607. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001
ClinicalTrials.gov study NCT02246816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Extension Study of Bifeprunox
ClinicalTrials.gov study NCT00366171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label Study to Evaluate G17DT Compared to Gemcitabine
ClinicalTrials.gov study NCT03200821. IPD Sharing: NO. Countries: 0. Publications: 0.
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
ClinicalTrials.gov study NCT06411145. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
ClinicalTrials.gov study NCT00542893. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.
ClinicalTrials.gov study NCT00645307. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor
ClinicalTrials.gov study NCT02015507. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
ClinicalTrials.gov study NCT02135276. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Observational Study of Meloxicam in Any Labeled Indication
ClinicalTrials.gov study NCT02182739. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01659047. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipi
ClinicalTrials.gov study NCT00154245. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
ClinicalTrials.gov study NCT00002072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Impact of Generic Labels on Compliance
ClinicalTrials.gov study NCT01862406. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
ClinicalTrials.gov study NCT04751955. IPD Sharing: NO. Countries: 0. Publications: 0.
An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
ClinicalTrials.gov study NCT01059084. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07084584. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.